Welcome to Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.


Anavex corporate presentation at 27th Annual ROTH Conference on March 11, 2015


Equities.com speaks with Christopher Missling, PhD., President and CEO of Anavex.